Literature DB >> 18774177

Prenatal dopamine and neonatal behavior and biochemistry.

Tiffany Field1, Miguel Diego, Maria Hernandez-Reif, Barbara Figueiredo, Osvelia Deeds, Angela Ascencio, Saul Schanberg, Cynthia Kuhn.   

Abstract

Depressed pregnant women (N=126) were divided into high and low prenatal maternal dopamine (HVA) groups based on a tertile split on their dopamine levels at 20 weeks gestation. The high versus the low dopamine group had lower Center for Epidemiological Studies-Depression Scale (CES-D) scores, higher norepinephrine levels at the 20-week gestational age visit and higher dopamine and serotonin levels at both the 20- and the 32-week gestational age visits. The neonates of the mothers with high versus low prenatal dopamine levels also had higher dopamine and serotonin levels as well as lower cortisol levels. Finally, the neonates in the high dopamine group had better autonomic stability and excitability scores on the Brazelton Neonatal Behavior Assessment Scale. Thus, prenatal maternal dopamine levels appear to be negatively related to prenatal depression scores and positively related to neonatal dopamine and behavioral regulation, although these effects are confounded by elevated serotonin levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774177      PMCID: PMC2610266          DOI: 10.1016/j.infbeh.2008.07.007

Source DB:  PubMed          Journal:  Infant Behav Dev        ISSN: 0163-6383


  16 in total

1.  Quantitation of plasma catecholamines by on-line trace enrichment high performance liquid chromatography with electrochemical detection.

Authors:  C D Kilts; M D Gooch; K D Knopes
Journal:  J Neurosci Methods       Date:  1984-09       Impact factor: 2.390

2.  The Brazelton Neonatal Behavior Assessment Scale: introduction.

Authors:  T B Brazelton
Journal:  Monogr Soc Res Child Dev       Date:  1978

3.  The association of the dopamine D4 receptor gene (DRD4) and the serotonin transporter promoter gene (5-HTTLPR) with temperament in 12-month-old infants.

Authors:  J G Auerbach; M Faroy; R Ebstein; M Kahana; J Levine
Journal:  J Child Psychol Psychiatry       Date:  2001-09       Impact factor: 8.982

Review 4.  The role of dopamine in reward and pleasure behaviour--review of data from preclinical research.

Authors:  R A Bressan; J A Crippa
Journal:  Acta Psychiatr Scand Suppl       Date:  2005

Review 5.  Neurobiological basis of depression: an update.

Authors:  Madhu Kalia
Journal:  Metabolism       Date:  2005-05       Impact factor: 8.694

6.  Visual exploratory behaviour in infancy and novelty seeking in adolescence: two developmentally specific phenotypes of DRD4?

Authors:  Manfred Laucht; Katja Becker; Martin H Schmidt
Journal:  J Child Psychol Psychiatry       Date:  2006-11       Impact factor: 8.982

7.  Use of a self-report symptom scale to detect depression in a community sample.

Authors:  J K Myers; M M Weissman
Journal:  Am J Psychiatry       Date:  1980-09       Impact factor: 18.112

Review 8.  Serotonin-dopamine interaction as a focus of novel antidepressant drugs.

Authors:  Ennio Esposito
Journal:  Curr Drug Targets       Date:  2006-02       Impact factor: 3.465

9.  Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament.

Authors:  R P Ebstein; J Levine; V Geller; J Auerbach; I Gritsenko; R H Belmaker
Journal:  Mol Psychiatry       Date:  1998-05       Impact factor: 15.992

Review 10.  Dopamine, depression and antidepressants.

Authors:  Eric Dailly; Franck Chenu; Caroline E Renard; Michel Bourin
Journal:  Fundam Clin Pharmacol       Date:  2004-12       Impact factor: 2.748

View more
  11 in total

1.  Prenatal serotonin and neonatal outcome: brief report.

Authors:  Tiffany Field; Miguel Diego; Maria Hernandez-Reif; Barbara Figueiredo; Osvelia Deeds; Angela Ascencio; Saul Schanberg; Cynthia Kuhn
Journal:  Infant Behav Dev       Date:  2008-02-14

Review 2.  Prenatal depression effects and interventions: a review.

Authors:  Tiffany Field; Miguel Diego; Maria Hernandez-Reif
Journal:  Infant Behav Dev       Date:  2010-05-14

Review 3.  Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation.

Authors:  S Brummelte; E Mc Glanaghy; A Bonnin; T F Oberlander
Journal:  Neuroscience       Date:  2016-02-22       Impact factor: 3.590

4.  Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.

Authors:  Amy L Salisbury; Katherine L Wisner; Teri Pearlstein; Cynthia L Battle; Laura Stroud; Barry M Lester
Journal:  Depress Anxiety       Date:  2011-09-02       Impact factor: 6.505

5.  The Role of Nutrition in Brain Development: The Golden Opportunity of the "First 1000 Days".

Authors:  Sarah E Cusick; Michael K Georgieff
Journal:  J Pediatr       Date:  2016-06-03       Impact factor: 4.406

6.  Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain-Part II.

Authors:  Atmaram Yarlagadda; Ganesh Acharya; Jayaprada Kasaraneni; Christiane S Hampe; Anita H Clayton
Journal:  Innov Clin Neurosci       Date:  2019-11-01

7.  Association of social and cognitive impairment and biomarkers in autism spectrum disorders.

Authors:  Altaf Alabdali; Laila Al-Ayadhi; Afaf El-Ansary
Journal:  J Neuroinflammation       Date:  2014-01-08       Impact factor: 8.322

8.  Environmental Intervention as a Therapy for Adverse Programming by Ancestral Stress.

Authors:  J Keiko McCreary; Zachary T Erickson; YongXin Hao; Yaroslav Ilnytskyy; Igor Kovalchuk; Gerlinde A S Metz
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

9.  Changes in Serotonin Modulation of Glutamate Currents in Pyramidal Offspring Cells of Rats Treated With 5-MT during Gestation.

Authors:  Gustavo Hernández-Carballo; Evelyn A Ruíz-Luna; Gustavo López-López; Elias Manjarrez; Jorge Flores-Hernández
Journal:  Brain Sci       Date:  2020-04-08

10.  Lifespan psychomotor behaviour profiles of multigenerational prenatal stress and artificial food dye effects in rats.

Authors:  Zachary T Erickson; Erin A Falkenberg; Gerlinde A S Metz
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.